Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07309471
NA

Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD

Sponsor: University Hospital, Basel, Switzerland

View on ClinicalTrials.gov

Summary

This study investigates DDH-LSD, a novel LSD-like compound expected to have a shorter duration of action than LSD. In healthy volunteers, pharmacokinetics, safety, and subjective effects, will be assessed and compare with LSD in a controlled cross-over study.

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2026-03-06

Completion Date

2028-07

Last Updated

2026-03-10

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

DDH-LSD

Single oral dose of DDH-LSD at the dose determined in Substudy 1. Participants are monitored for 13 hours for pharmacokinetics, subjective effects, autonomic responses, and safety parameters.

DRUG

LSD

Single oral dose of 0.1 mg LSD. Participants are monitored for 13 hours for pharmacokinetics, subjective effects, autonomic responses, and safety parameters.

DRUG

Placebo

Single oral administration of placebo. Participants are monitored for 13 hours under identical conditions to control for expectancy and procedural effects.

Locations (1)

University Hospital Basel

Basel, Switzerland